Ceribell Receives FDA Clearance for Advanced AI EEG Detection
Sunnyvale, Calif., August 10, 2026 Ceribell, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Sunnyvale, Calif., August 10, 2026 Ceribell, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
Waltham, Mass., August 10, 2026 Spyre Therapeutics, Inc. announced the launch of its SPY772 combination program and initiation of...
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
San Francisco, California, USA, August 10, 2026 Avere Therapeutics, Inc. has announced a $500 million private placement from a...
Staten Island, New York, USA, August 10, 2026 Acurx Pharmaceuticals, Inc. has announced a new scientific partnership with Leiden...
Cambridge, Massachusetts, USA, August 8, 2026 Biogen has completed the acquisition of RayThera Inc., a privately held biotechnology company...
San Diego, California, USA, August 8, 2026 Blacksmith Medicines has announced the publication of new research in the Journal...
South San Francisco, California, August 6, 2026 Olio Labs has presented a new AI-driven in vivo drug discovery platform...
OSAKA, Japan & BOSTON, Mass., August 6, 2026 Ono Pharmaceutical Co., Ltd. announced a drug discovery partnership and option...
Cold Spring Harbor, New York, August 5, 2026 Cold Spring Harbor Laboratory (CSHL) and Northwell Health have helped lead...
